192 related articles for article (PubMed ID: 26697500)
21. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals.
Fenzl A; Itariu BK; Kosi L; Fritzer-Szekeres M; Kautzky-Willer A; Stulnig TM; Kiefer FW
Diabetologia; 2014 Jun; 57(6):1204-8. PubMed ID: 24623100
[TBL] [Abstract][Full Text] [Related]
22. Positive Association Between Betatrophin and Diabetic Retinopathy Risk in Type 2 Diabetes Patients.
Wang YY; Zhang D; Jiang ZY; Lu XQ; Zheng X; Yu YJ; Wang YG; Dong J
Horm Metab Res; 2016 Mar; 48(3):169-73. PubMed ID: 26863068
[TBL] [Abstract][Full Text] [Related]
23. Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function.
Chen CC; Susanto H; Chuang WH; Liu TY; Wang CH
Cardiovasc Diabetol; 2016 Jan; 15():3. PubMed ID: 26739836
[TBL] [Abstract][Full Text] [Related]
24. Circulating betatrophin is elevated in patients with type 1 and type 2 diabetes.
Yamada H; Saito T; Aoki A; Asano T; Yoshida M; Ikoma A; Kusaka I; Toyoshima H; Kakei M; Ishikawa SE
Endocr J; 2015; 62(5):417-21. PubMed ID: 25753914
[TBL] [Abstract][Full Text] [Related]
25. Circulating betatrophin concentration is negatively correlated with insulin resistance in obese children and adolescents.
Tuhan H; Abacı A; Anık A; Çatlı G; Küme T; Çalan ÖG; Acar S; Böber E
Diabetes Res Clin Pract; 2016 Apr; 114():37-42. PubMed ID: 27103367
[TBL] [Abstract][Full Text] [Related]
26. Higher plasma betatrophin/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance.
Abu-Farha M; Abubaker J; Al-Khairi I; Cherian P; Noronha F; Hu FB; Behbehani K; Elkum N
Sci Rep; 2015 Jun; 5():10949. PubMed ID: 26077345
[TBL] [Abstract][Full Text] [Related]
27. Circulating betatrophin concentrations are decreased in human obesity and type 2 diabetes.
Gómez-Ambrosi J; Pascual E; Catalán V; Rodríguez A; Ramírez B; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2004-9. PubMed ID: 25050901
[TBL] [Abstract][Full Text] [Related]
28. Circulating serum irisin levels in obesity and type 2 diabetes mellitus.
Shoukry A; Shalaby SM; El-Arabi Bdeer S; Mahmoud AA; Mousa MM; Khalifa A
IUBMB Life; 2016 Jul; 68(7):544-56. PubMed ID: 27220658
[TBL] [Abstract][Full Text] [Related]
29. Characterisation of betatrophin concentrations in childhood and adolescent obesity and insulin resistance.
Wu S; Gao H; Ma Y; Fu L; Zhang C; Luo X
Pediatr Diabetes; 2016 Feb; 17(1):53-60. PubMed ID: 25413012
[TBL] [Abstract][Full Text] [Related]
30. Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery.
Ejarque M; Borlaug M; Vilarrasa N; Martinez-Perez B; Llauradó G; Megía A; Helland T; Gutierrez C; Serena C; Folkestad O; Nuñez-Roa C; Roche K; Casajoana A; Fradera R; González-Clemente JM; López M; Mohn AC; Nedrebø BG; Nogueiras R; Mellgren G; Fernø J; Fernández-Veledo S; Vendrell J
Transl Res; 2017 Jun; 184():35-44.e4. PubMed ID: 28347650
[TBL] [Abstract][Full Text] [Related]
31. Assessment of circulating betatrophin concentrations in lean glucose-tolerant women with polycystic ovary syndrome.
Erol O; Özel MK; Ellidağ HY; Toptaş T; Derbent AU; Yılmaz N
J Obstet Gynaecol; 2017 Jul; 37(5):633-638. PubMed ID: 28319674
[TBL] [Abstract][Full Text] [Related]
32. Altered Concentrations in Dyslipidemia Evidence a Role for ANGPTL8/Betatrophin in Lipid Metabolism in Humans.
Gómez-Ambrosi J; Pascual-Corrales E; Catalán V; Rodríguez A; Ramírez B; Romero S; Vila N; Ibáñez P; Margall MA; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2016 Oct; 101(10):3803-3811. PubMed ID: 27472196
[TBL] [Abstract][Full Text] [Related]
33. An explanation for recent discrepancies in levels of human circulating betatrophin.
Fu Z; Abou-Samra AB; Zhang R
Diabetologia; 2014 Oct; 57(10):2232-4. PubMed ID: 25099942
[No Abstract] [Full Text] [Related]
34. Maternal and cord blood betatrophin (angiopoietin-like protein 8) in pregnant women with gestational diabetes and normoglycemic controls: A systematic review, meta-analysis, and meta-regression.
Pérez-López FR; Yuan J; Sánchez-Prieto M; López-Baena MT; Pérez-Roncero GR; Varikasuvu SR
Diabetes Metab Res Rev; 2023 May; 39(4):e3612. PubMed ID: 36656279
[TBL] [Abstract][Full Text] [Related]
35. Role of Betatrophin and Inflammation Markers in Type 2 Diabetes Mellitus, Prediabetes and Metabolic Syndrome.
Onalan E; Bozkurt A; Gursu MF; Yakar B; Donder E
J Coll Physicians Surg Pak; 2022 Mar; 32(3):303-307. PubMed ID: 35148580
[TBL] [Abstract][Full Text] [Related]
36. Serum betatrophin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome.
Qu Q; Zhao D; Zhang F; Bao H; Yang Q
J Int Med Res; 2017 Feb; 45(1):193-202. PubMed ID: 28222635
[TBL] [Abstract][Full Text] [Related]
37. Correlation of circulating betatrophin concentrations with insulin secretion capacity, evaluated by glucagon stimulation tests.
Tokumoto S; Hamamoto Y; Fujimoto K; Yamaguchi E; Okamura E; Honjo S; Ikeda H; Wada Y; Hamasaki A; Koshiyama H
Diabet Med; 2015 May; 32(5):653-6. PubMed ID: 25655786
[TBL] [Abstract][Full Text] [Related]
38. Elevated circulating lipasin/betatrophin in human type 2 diabetes and obesity.
Fu Z; Berhane F; Fite A; Seyoum B; Abou-Samra AB; Zhang R
Sci Rep; 2014 May; 4():5013. PubMed ID: 24852694
[TBL] [Abstract][Full Text] [Related]
39. Association between betatrophin/ANGPTL8 and non-alcoholic fatty liver disease: animal and human studies.
Lee YH; Lee SG; Lee CJ; Kim SH; Song YM; Yoon MR; Jeon BH; Lee JH; Lee BW; Kang ES; Lee HC; Cha BS
Sci Rep; 2016 Apr; 6():24013. PubMed ID: 27045862
[TBL] [Abstract][Full Text] [Related]
40. Gender-Dependent Associations between Serum Betatrophin Levels and Lipoprotein Subfractions in Diabetic and Nondiabetic Obese Patients.
Lőrincz H; Csiha S; Ratku B; Somodi S; Sztanek F; Seres I; Paragh G; Harangi M
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
